FDA’s Drug Shortage Reg Adds More Manufacturers, Products To Notification List
Executive Summary
Interim final rule redefines the terms “sole manufacturer” and “discontinuance.”
You may also be interested in...
Drug Shortage Prevention May Fall To Payers As FDA Rolls Out New Reg
Even as agency touts its progress and expands its powers, it acknowledges the limits of notification.
Compounding: How Does FDA Expand Oversight Without Legislation?
After House Republicans indicate legislation expanding agency’s oversight of compounding is unlikely, FDA could consider other regulatory options, like changing internal policies or hoping a court clarifies its regulatory authority.
Compounding: How Does FDA Expand Oversight Without Legislation?
After House Republicans indicate legislation expanding agency’s oversight of compounding is unlikely, FDA could consider other regulatory options, like changing internal policies or hoping a court clarifies its regulatory authority.